Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer

NCT03180437 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
62
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fuda Cancer Hospital, Guangzhou

Collaborators